Fulcrum Therapeutics
FULC
#8396
Rank
โ‚ฌ0.25 B
Marketcap
3,36ย โ‚ฌ
Share price
-0.54%
Change (1 day)
-65.69%
Change (1 year)

Earnings for Fulcrum Therapeutics (FULC)

Earnings in 2026 (TTM): -โ‚ฌ74.56 Million

According to Fulcrum Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -โ‚ฌ77.28 Million a decrease over its 2024 earnings that were of -โ‚ฌ18.09 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Fulcrum Therapeutics from 2018 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ74.56 Million-3.52%
2025 -โ‚ฌ77.28 Million327.39%
2024 -โ‚ฌ18.09 Million-82.08%
2023 -โ‚ฌ0.11 Billion-1.31%
2022 -โ‚ฌ0.11 Billion38.34%
2021 -โ‚ฌ73.89 Million13.19%
2020 -โ‚ฌ65.29 Million-14.97%
2019 -โ‚ฌ76.78 Million151.41%
2018 -โ‚ฌ30.54 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-โ‚ฌ0.15 Billion 80.21%๐Ÿ‡บ๐Ÿ‡ธ USA